Inside AI-Powered Drug Discovery with Gain Therapeutics’ CEO Gene Mack

In this episode of the Xtalks Life Science Podcast, Vera Kovacevic speaks with Gene Mack, CEO and President of Gain Therapeutics, a company focused on AI-driven small molecule discovery for diseases with high unmet medical needs.

With over 25 years of leadership across biopharma, capital markets and corporate strategy, Gene shares his unique perspective on the intersection of artificial intelligence and drug development — and how Gain Therapeutics is using it to tackle diseases with high unmet medical need.

Prior to joining Gain, Gene was CFO at Imcyse SA between 2021 and 2023, and at OncoC4, which spun out of Merck’s acquisition of OncoImmune in 2020 where he had also been CFO.

Gene discusses his career journey from Wall Street to the C-suite, his experience raising over $350 million in biotech funding and the exciting science behind Gain’s drug discovery platform.

Gene received both his Bachelor of Science in biochemistry and MBA in finance from Fordham University.

Whether you're a biotech investor, drug developer or simply curious about how AI is reshaping the future of medicine, tune into the conversation.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/

Follow Us on Social Media

Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured